2024 Early Hearing Detection & Intervention Conference
March 17-19, 2024 • Denver, CO
| Overcoming Obstacles: Navigating the Management of Children with Hearing Loss and Congenital CMV
Overcoming Obstacles: Navigating the Management of Children with Hearing Loss and Congenital CMV
Congenital Cytomegalovirus (cCMV) and its characteristics pose one of the greatest threats to undiagnosed hearing loss in children. According to the Centers for Disease Control and Prevention (CDC), one out of every five babies with cCMV will have long-term health conditions, such as hearing loss. Although hearing loss is common in children with cCMV, the characteristics, severity, progression, and onset for each child may vary. Hearing loss can occur unilaterally or bilaterally, progressively or late-onset, and from mild to profound in severity. The diverse impact of cCMV causes a higher risk of hearing loss going undetected.
Currently, Florida does not have a state-based audiological monitoring protocol for cCMV. The risk of not having mandated state monitoring protocols can lead to progressive hearing loss going undetected in children. The monitoring protocols that do exist vary by state, and there is no consensus on strategies to help overcome and avoid the risks of late identification of hearing loss in children with cCMV. The demonstration of these case studies will aim to highlight the variability of the hearing loss profile in children with cCMV. These case studies will exemplify the importance of early intervention and describe barriers to diagnosing hearing loss in children with cCMV. This poster will additionally identify obstacles and the related countermeasures that are present when diagnosing hearing loss in a child with cCMV. This poster will list strategies for preventing loss to follow-up that can be implemented in clinical practice.
- The participants will be able to describe the importance of early intervention in patients with CMV.
- The participants will be able to identify barriers in diagnosing children with CMV.
- The participants will be able to list strategies for preventing loss to follow-up.
Presentation:
This presentation has not yet been uploaded.
Handouts:
Handout is not Available
Transcripts:
CART transcripts are NOT YET available, but will be posted shortly after the conference
Presenters/Authors
Melissa Lorquet
(Primary Presenter,Author), University of Miami Ear Institute , Mxl2348@med.miami.edu;
Melissa Lorquet is an Audiology Pediatric Extern at the University of Miami Ear Institute Children's Hearing Program and a LEND Trainee at Mailman Center for Child Development. She is pursing her Doctorate of Audiology (Au.D) at Nova Southeastern University and received a Bachelors in Linguistics at the University of Florida. Her clinical interests are in auditory electrophysiology and cochlear implantation.
ASHA DISCLOSURE:
Financial -
No relevant financial relationship exists.
Nonfinancial -
No relevant nonfinancial relationship exists.
AAA DISCLOSURE:
Financial -
No relevant financial relationship exists.
Nonfinancial -
No relevant nonfinancial relationship exists.
Chrisanda Sanchez
(Author,Co-Author), University of Miami Department of Otolaryngology, cmsanchez@med.miami.edu;
Dr. Chrisanda Sanchez is a bilingual pediatric audiologist at the University of Miami. She is an Assistant Professor in the Department of Otolaryngology, the lead pediatric cochlear implant audiologist, and Interim Director of the Children’s Hearing Program at the University of Miami. She has extensive experience in pediatric cochlear implantation, educational audiology, and management of bilingual patients. Dr. Sanchez’s clinical career has centered around pediatrics, specializing in pediatric cochlear implants, hearing aids, and other implantable devices. Her research focuses on mental health, pediatrics, bilingualism, and implantable devices, specifically targeting pediatric cochlear implantation and outcomes.
ASHA DISCLOSURE:
Financial -
Nonfinancial -
AAA DISCLOSURE:
Financial -
Nonfinancial -